We are live on ! Find out more
PTVE

Pactiv Evergreen Inc. Common stock

Delisted

PTVE was delisted on the 31st of March, 2025.

68 hedge funds and large institutions have $604M invested in Pactiv Evergreen Inc. Common stock in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

89% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 18

10% more capital invested

Capital invested by funds: $547M → $604M (+$57M)

11% less funds holding

Funds holding: 7668 (-8)

50% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 16

Holders
68
Holders Change
-8
Holders Change %
-10.53%
% of All Funds
1.18%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.07%
New
8
Increased
34
Reduced
18
Closed
16
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$137K
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$203K +$31.4K +2,094 +18%
ASRS
52
Arizona State Retirement System
Arizona
$181K +$181K +12,039 New
Man Group
53
Man Group
United Kingdom
$175K +$174K +11,625 New
Bank of America
54
Bank of America
North Carolina
$169K -$666K -44,395 -80%
ProShare Advisors
55
ProShare Advisors
Maryland
$168K +$8.85K +590 +6%
Federated Hermes
56
Federated Hermes
Pennsylvania
$164K +$158K +10,547 +3,235%
FMT
57
First Mercantile Trust
Tennessee
$161K +$13.3K +889 +9%
Cerity Partners
58
Cerity Partners
New York
$151K
Legal & General Group
59
Legal & General Group
United Kingdom
$91K +$38.2K +2,545 +74%
AIP
60
Ameritas Investment Partners
Nebraska
$50K
Citigroup
61
Citigroup
New York
$43K +$3.65K +243 +9%
MA
62
Montag & Associates
Georgia
$27K
TRCT
63
Tower Research Capital (TRC)
New York
$25K -$85.3K -5,687 -78%
UBS Group
64
UBS Group
Switzerland
$12K -$111K -7,411 -90%
Rockefeller Capital Management
65
Rockefeller Capital Management
New York
$9K +$9K +600 New
Group One Trading
66
Group One Trading
Illinois
$6K
CAPTRUST Financial Advisors
67
CAPTRUST Financial Advisors
North Carolina
$6K +$2.25K +150 +60%
AIG
68
American International Group
New York
$363 +$15.8K +1,051 +5%
CCM
69
CAAS Capital Management
New York
-$2.94M -214,353 Closed
Norges Bank
70
Norges Bank
Norway
-$2.37M -172,186 Closed
California Public Employees Retirement System
71
California Public Employees Retirement System
California
-$1.12M -81,426 Closed
Stifel Financial
72
Stifel Financial
Missouri
-$737K -53,640 Closed
ECM
73
ExodusPoint Capital Management
New York
-$343K -24,935 Closed
Los Angeles Capital Management
74
Los Angeles Capital Management
California
-$330K -24,030 Closed
Bank of Montreal
75
Bank of Montreal
Ontario, Canada
-$301K -20,890 Closed

PTVE Hedge Fund Activity: Q2 2021 in Review

68 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q2 2021, worth a combined $604M — up 10% from $547M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of PTVE and 8 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 34 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $20M. The largest seller was Nuveen, cutting an estimated $26.4M.

  • 68 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q2 2021, down from 76 in Q1 2021.
  • Funds reported $604M of Pactiv Evergreen Inc. Common stock stock for Q2 2021, up 10% quarter-over-quarter.
  • 8 funds opened new Pactiv Evergreen Inc. Common stock positions in Q2 2021 and 16 closed out, a net change of -8 holders.
  • The largest Pactiv Evergreen Inc. Common stock buyer in Q2 2021 was Rubric Capital Management (New York), an estimated $20M added.
  • The largest Pactiv Evergreen Inc. Common stock seller in Q2 2021 was Nuveen, an estimated $26.4M sold.

Based on aggregated 13F filings for Q2 2021.